Related Articles
Triple‑negative breast cancer therapy: Current and future perspectives (Review)
Photosensitizer verteporfin inhibits the growth of YAP‑ and TAZ‑dominant gastric cancer cells by suppressing the anti‑apoptotic protein Survivin in a light‑independent manner
High expression of FUSE binding protein 1 in breast cancer stimulates cell proliferation and diminishes drug sensitivity Corrigendum in /10.3892/ijo.2021.5210
The scaffolding protein NHERF1 sensitizes EGFR-dependent tumor growth, motility and invadopodia function to gefitinib treatment in breast cancer cells
Elevated estrogen receptor β expression in triple negative breast cancer cells is associated with sensitivity to doxorubicin by inhibiting the PI3K/AKT/mTOR signaling pathway